Literature DB >> 23880146

Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates.

Elena Capel1, Mariona Parera, Bonaventura Clotet, Miguel Angel Martínez.   

Abstract

During the human immunodeficiency virus type 1 (HIV-1) pandemic, continuous, extensive genetic diversification of the virus has been observed. To study the effect of HIV-1 diversification on integrase-associated viral replication capacity (RC), 94 HIV-1 subtype B integrase sequences from two groups of antiretroviral-naive viruses isolated 15 y apart were amplified and recombined with an HIV-1 infectious clone. Viral RC was determined by infecting a T cell line with a long terminal repeat-driven green fluorescent protein reporter. Significant differences in integrase-mediated RC were observed between recombinant viruses from early and late isolates (p=0.0286). Integrases from late isolates had significantly lower sequence conservation scores compared to an ancestral subtype B sequence (p<0.0001). Integrase amino acid polymorphisms S17N, I72V, S119P, and D256E were associated with a lower ex vivo viral RC. These results suggest that integrase sequence diversification has affected ex vivo HIV-1 RC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diversification; Fitness; HIV; Integrase

Mesh:

Substances:

Year:  2013        PMID: 23880146     DOI: 10.1016/j.virol.2013.06.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Epistasis as a determinant of the HIV-1 protease's robustness to mutation.

Authors:  Elena Capel; Mariona Parera; Miguel Angel Martinez
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

2.  Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.

Authors:  Alina Kirichenko; Ilya Lapovok; Pavel Baryshev; David A M C van de Vijver; Jeroen J A van Kampen; Charles A B Boucher; Dimitrios Paraskevis; Dmitry Kireev
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.